Literature DB >> 22306780

Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Kelly L McCoy1, Stefka Gyoneva, Christopher P Vellano, Alan V Smrcka, Stephen F Traynelis, John R Hepler.   

Abstract

Protease-activated receptor 1 (PAR1) is an unusual GPCR that interacts with multiple G protein subfamilies (G(q/11), G(i/o), and G(12/13)) and their linked signaling pathways to regulate a broad range of pathophysiological processes. However, the molecular mechanisms whereby PAR1 interacts with multiple G proteins are not well understood. Whether PAR1 interacts with various G proteins at the same, different, or overlapping binding sites is not known. Here we investigated the functional and specific binding interactions between PAR1 and representative members of the G(q/11), G(i/o), and G(12/13) subfamilies. We report that G(q/11) physically and functionally interacts with specific amino acids within the second intracellular (i2) loop of PAR1. We identified five amino acids within the PAR1 i2 loop that, when mutated individually, each markedly reduced PAR1 activation of linked inositol phosphate formation in transfected COS-7 cells (functional PAR1-null cells). Among these mutations, only R205A completely abolished direct G(q/11) binding to PAR1 and also PAR1-directed inositol phosphate and calcium mobilization in COS-7 cells and PAR1-/- primary astrocytes. In stark contrast, none of the PAR1 i2 loop mutations disrupted direct PAR1 binding to either G(o) or G(12), or their functional coupling to linked pertussis toxin-sensitive ERK phosphorylation and C3 toxin-sensitive Rho activation, respectively. In astrocytes, our findings suggest that PAR1-directed calcium signaling involves a newly appreciated G(q/11)-PLCε pathway. In summary, we have identified key molecular determinants for PAR1 interactions with G(q/11), and our findings support a model where G(q/11), G(i/o) or G(12/13) each bind to distinct sites within the cytoplasmic regions of PAR1.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306780      PMCID: PMC3319227          DOI: 10.1016/j.cellsig.2012.01.011

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  50 in total

1.  Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.

Authors:  Joseph N McLaughlin; Lixin Shen; Michael Holinstat; Joshua D Brooks; Emmanuele Dibenedetto; Heidi E Hamm
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

2.  Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism.

Authors:  Steven Swift; Andrew J Leger; Joyce Talavera; Lei Zhang; Andrew Bohm; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2005-12-13       Impact factor: 5.157

Review 3.  Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Authors:  S R Coughlin
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

4.  Astrocytic control of synaptic NMDA receptors.

Authors:  C Justin Lee; Guido Mannaioni; Hongjie Yuan; Dong Ho Woo; Melissa B Gingrich; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

5.  Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.

Authors:  Mina Ito; Taku Nagai; Hiroyuki Kamei; Noritaka Nakamichi; Toshitaka Nabeshima; Kazuhiro Takuma; Kiyofumi Yamada
Journal:  Mol Pharmacol       Date:  2006-08-14       Impact factor: 4.436

6.  G-protein-coupled receptor agonists activate endogenous phospholipase Cepsilon and phospholipase Cbeta3 in a temporally distinct manner.

Authors:  Grant G Kelley; Katherine A Kaproth-Joslin; Sarah E Reks; Alan V Smrcka; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

7.  The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.

Authors:  Taku Nagai; Mina Ito; Noritaka Nakamichi; Hiroyuki Mizoguchi; Hiroyuki Kamei; Ayumi Fukakusa; Toshitaka Nabeshima; Kazuhiro Takuma; Kiyofumi Yamada
Journal:  J Neurosci       Date:  2006-11-22       Impact factor: 6.167

8.  Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation.

Authors:  Simona Citro; Sundeep Malik; Emily A Oestreich; Julie Radeff-Huang; Grant G Kelley; Alan V Smrcka; Joan Heller Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

9.  Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.

Authors:  Melinda D Hains; Michele R Wing; Savitri Maddileti; David P Siderovski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2006-03-22       Impact factor: 4.436

Review 10.  Protease-activated receptor signaling: new roles and regulatory mechanisms.

Authors:  Stephen F Traynelis; Joann Trejo
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

View more
  19 in total

1.  Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar.

Authors:  Omozuanvbo Aisiku; Christian G Peters; Karen De Ceunynck; Chandra C Ghosh; James R Dilks; Susanna F Fustolo-Gunnink; Mingdong Huang; Chris Dockendorff; Samir M Parikh; Robert Flaumenhaft
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

2.  N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.

Authors:  Antonio G Soto; Thomas H Smith; Buxin Chen; Supriyo Bhattacharya; Isabel Canto Cordova; Terry Kenakin; Nagarajan Vaidehi; JoAnn Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

3.  Activation of astrocytic PAR1 receptors in the rat nucleus of the solitary tract regulates breathing through modulation of presynaptic TRPV1.

Authors:  Rafiq Huda; Zheng Chang; Jeehaeh Do; Donald R McCrimmon; Marco Martina
Journal:  J Physiol       Date:  2018-01-15       Impact factor: 5.182

Review 4.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 5.  Thrombin generation and atherosclerosis.

Authors:  Jana Kalz; Hugo ten Cate; Henri M H Spronk
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

6.  The thrombin receptor modulates astroglia-neuron trophic coupling and neural repair after spinal cord injury.

Authors:  Ha Neui Kim; Erin M Triplet; Maja Radulovic; Samantha Bouchal; Laurel S Kleppe; Whitney L Simon; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2021-04-22       Impact factor: 8.073

7.  Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.

Authors:  Amal Arachiche; María de la Fuente; Marvin T Nieman
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 8.  Thrombin regulation of synaptic transmission and plasticity: implications for health and disease.

Authors:  Marina Ben Shimon; Maximilian Lenz; Benno Ikenberg; Denise Becker; Efrat Shavit Stein; Joab Chapman; David Tanne; Chaim G Pick; Ilan Blatt; Miri Neufeld; Andreas Vlachos; Nicola Maggio
Journal:  Front Cell Neurosci       Date:  2015-04-21       Impact factor: 5.505

9.  Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells.

Authors:  Sungho Ghil; Kelly L McCoy; John R Hepler
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

Review 10.  Differential signaling by protease-activated receptors: implications for therapeutic targeting.

Authors:  Tejminder S Sidhu; Shauna L French; Justin R Hamilton
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.